Article
RAS: Circuitry and therapeutic targeting.
Cellular signalling - 1 Jan 2023
Singh Gagandeep, Thakur Neelam, Kumar Umesh
Abstract excerpt
Cancer has affected the lives of millions worldwide and is truly regarded as a devastating disease process. Despite advanced understanding of the genomic underpinning of cancer development and progression, therapeutic challenges are still persistent. Among all the human cancers, around 33% are attributed to mutations in RAS oncogene, a crucial component of the signaling pathways. With time, our understanding of...
Topics
Join the communities discussing this publication.
